
A phase I-B trial of the radiosensitizer: Etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02)
Keywords: Etanidazole; SR-2508; Radiosurgery; Brain tumors